Cherry SE Convenes Extraordinary General Meeting to Address Financial Restructuring

Cherry SE, a global manufacturer of computer input devices and digital healthcare solutions, has convened an Extraordinary General Meeting scheduled for May 22, 2026. The primary agenda item is a resolution for a reverse share split in a ratio of 4:1. This corporate action is intended to offset accumulated balance sheet losses and restore the company's capital market eligibility, which is crucial for pursuing future financing options to support restructuring and growth initiatives.

The company is currently evaluating various financing options to fund its ongoing restructuring and strategic growth plans. The reverse share split, if approved, would establish necessary prerequisites for such potential financing measures. The decision to hold an Extraordinary General Meeting stems from the delayed timing of the Annual General Meeting, which has been postponed due to the extended timeline for completing the annual financial report. A change of auditor and related first-time audit procedures have required additional time beyond original expectations, leading to the rescheduling of the annual financial report publication to July 15, 2026.

By convening the Extraordinary General Meeting separately, Cherry SE ensures that the process to restore its capital market eligibility can proceed independently of the revised financial reporting schedule. The company had previously published preliminary results for the 2025 fiscal year on March 5, 2026. Investors can access the full Q1/2025 quarterly financial report for download from the company's investor relations website starting May 7, 2026. For further information, visit https://ir.cherry.de/en/.

The implications of this announcement are significant for shareholders and potential investors. The reverse share split represents a strategic move to strengthen the company's financial structure and improve its standing in capital markets. This is particularly important as Cherry SE seeks financing for its restructuring efforts, which are critical for its future competitiveness in both the computer peripherals and digital healthcare sectors. The delay in the annual financial report, while attributed to audit transitions, underscores the complexities involved in the company's current financial repositioning.

For the broader market, this development highlights the challenges faced by established technology manufacturers navigating post-pandemic market conditions and evolving industry demands. Cherry SE's actions reflect a proactive approach to addressing balance sheet issues while maintaining operational transparency through scheduled financial disclosures. The company's ability to secure financing and successfully execute its restructuring plan will likely influence its long-term viability and capacity to innovate in its core markets of gaming, office peripherals, and digital healthcare solutions.